By building a novel innovation platform, Shuwen and its top partners in many countries or regions around the world have jointly developed forward-looking innovative diagnostic products, forming an advanced technology development model based on China and facing the world, which brings sustainable innovation capability to Shuwen. CapCord® Pre-Eclampsia detection kit is one of the examples of Shuwen's innovation platform. This kit is a first-in-class and China-originated product developed by Shuwen in cooperation with Yale University based on a novel, patented biomarker "misfolded protein". Shuwen exclusively authorized this product to Perkin Elmer, an international IVD industry giant and a global leader in maternal and infant diagnosis. This transaction was evaluated by McKinsey in its annual report on China's medical technology field as "a typical representative of the new era of global cooperation for Chinese companies in the medical technology industry".